The role of cytokines, coagulation, and fibrinolysis in peritoneal tissue repair

European Journal of Surgery

Volumn 165, Issue 11, 1999, Pages 1012-1019

  Holmdahl, Lena ^a   Ivarsson, Marie Louise ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Adhesion formation; Interleukin 1; Interleukin 10; Interleukin 6; Interleukin 8; Plasminogen activator inhibitor type 1; Tissue factor; Tissue type plasminogen activator; Transforming growth factor beta; Tumor necrosis factor alpha

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

BLOOD CLOTTING; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FIBRIN DEPOSITION; FIBRINOLYSIS; HUMAN; MESOTHELIUM; NONHUMAN; PATHOPHYSIOLOGY; PERITONEUM ADHESION; PRIORITY JOURNAL; REVIEW; TISSUE REPAIR; WOUND HEALING;

EID: 0032726838     PISSN: 11024151     EISSN: None     Source Type: Journal    
DOI: 10.1080/110241599750007810     Document Type: Review

References (68)

1. Badia JM, Whawell SA, Scott-Coombes DM, Waghorn AJ, Abel PD, Thompson JN. The peritoneal cytokine profile in acute peritonitis. In: Treutner K-H, Schumpelick V, eds. Peritoneal adhesions. Berlin: Springer, 1997: 197-200.
2. Baigrie RJ, Lamont PM, Dallman M, Morris PJ. The release of interleukin-1b (II-1) precedes that of interleukin 6 (II-6) in patients undergoing major surgery. Lymphokine Res 1991; 10: 253-256.
3. Betjes MG, Tuk CW, Struijk DG, et al. Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor-a, interleukin-1, and medium conditioned by macrophages cocultured with staphylococcus epidermidis. J Infect Dis 1993; 168: 1202-1210.
4. Bilgin T, Cengiz C, Demir U. Postoperative adhesion formation following ovarian reconstruction with fibrin glue in the rabbit. Gynecol Obstet Invest 1995; 39: 186-187.
5. Border WA, Noble NA. Transforming growth factor β in tissue fibrosis. N Engl J Med 1994; 331: 1286-1292.
6. Byrne DJ, Hardy J, Wood RA, McIntosh R, Hopwood D, Cuschieri A. Adverse influence of fibrin sealant on the healing of high-risk sutured colonic anastomoses. J R Coll Surg Edinb 1992; 37: 394-398.
7. Chegini N, Gold LI, Williams RS, Masterson BJ. Localization of transforming growth factor beta isoforms TGF-beta 1, TGF-beta 2, and TGF-beta 3 in surgically induced pelvic adhesions in the rat. Obstet Gynecol 1994; 83: 449-454.
8. de Virgilo C, Dubrow T, Sheppard BB, et al. Fibrin glue inhibits intra-abdominal adhesion formation. Arch Surg 1990; 125: 1378-1381.
9. Doody KJ, Dunn RC, Buttram VC. Recombinant tissue plasminogen activator reduces adhesion formation in a rabbit uterine horn model. Fertil Steril 1989; 51: 509-512.
10. Dörr PJ, Vemer HM, Brommer EJP, Willemsen WNP, Veldhuizen RW, Rolland R. Prevention of postoperative adhesions by tissue-type plasminogen activator (t-PA) in the rabbit. Eur J Obstet Gynecol Reprod Biol 1990; 37: 287-291.
11. Douvdevani A, Rapoport J, Konforty A, Argov S, Ovnat A, Chaimovitz C. Human peritoneal mesothelial cells synthesize IL-1 alpha and beta. Kidney Int 1994; 46: 993-1001.
12. Dunn RC, Buttram VC. Tissue-type plasminogen activator as an adjuvant for post surgical adhesions. Prog Clin Biol Res 1990; 358: 113-118.
13. Dunn RC, Mohler M. Effect of varying days of plasminogen activator therapy on the prevention of postsurgical adhesions in a rabbit model. J Surg Res 1993; 54: 242-245.
14. Ellis H, Harrison W, Hugh TB. The healing of peritoneum under normal and pathological conditions. Br J Surg 1965; 52: 471-476.
15. Eskeland G. Regeneration of parietal peritoneum in rats. A light microscopical study. Acta Path Microbiol Scand 1966; 68: 355-378.
16. Evans DM, McAree K, Guyton DP, Hawkins N, Stakleff K. Dose dependency and wound healing aspects of the use of tissue plasminogen activator in the prevention of intra-abdominal adhesions. Am J Surg 1993; 165: 229-232.
17. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-3822.
18. Gauwerky JFH, Mann J, Basiert G. The effect of fibrin glue and peritoneal grafts in the prevention of intraperitoneal adhesions. Arch Gynecol Obstet 1990; 247: 161-166.
19. Griffith DE, Johnson AR, Kumar A, Holiday DB, Idell S. Growth factors for human pleural mesothelial cells in soluble products from formed clots. Thromb Res 1994; 74: 207-218.
20. Harris ES, Morgan RF, Rodeheaver GT. Analysis of the kinetics of peritoneal adhesion formation in the rat and evaluation of potential antiadhesive agents. Surgery 1995; 117: 663-669.
21. Hashimoto Y, Hirohata S, Kashiwado T, Itoh K, Ishii H. Cytokine regulation of hemostatic property and IL-6 production of human endothelial cells. Inflammation 1992; 16: 613-621.
22. Holmdahl L, Al-Jabreen M, Risberg B. Experimental models for quantitative studies on adhesion formation in rats and rabbits. Eur Surg Res 1994; 26: 248-256.
23. Holmdahl L, Al-Jabreen M, Risberg B. The role of fibrinolysis in the formation of postoperative adhesions. Wound Rep Reg 1994; 7: 171-176.
24. Holmdahl L, Bluhm R, Ivarsson M-L, Bergström M, Chegini N. Cellular localization of the plasmin system and TGF-β in peritoneum in inflammatory and noninflammatory conditions. (Submitted).
25. Holmdahl L, Eriksson E, Eriksson BI, Risberg B. Depression of Peritoneal fibrinolysis during surgery is a local response to trauma. Surgery 1998; 123: 539-544.
26. Holmdahl L, Eriksson E, Risberg B. Fibrinolysis in human peritoneum during operation. Surgery 1996; 119: 701-705.
27. Holmdahl L, Falkenberg M, Ivarsson ML, Risberg B. Plasminogen activator and inhibitors in peritoneal tissue. APMIS 1997; 105: 25-30.
28. Holmdahl L, Kotseos K, Bergström M, Falk P, Ivarsson M-L, Chegini N. Overproduction of transforming growth factor beta (TGF-β) is associated with adhesion formation and peritoneal fibrinolytic impairment. (Submitted).
29. Ivarsson M-L, Bergström M, Eriksson E, Risberg B, Holmdahl L. Tissue markers as predictors of postsurgical adhesions. Br J Surg 1998; 85: 1549-1554.
30. Ivarsson M-L, Holmdahl L, Eriksson E, Söderberg R, Risberg B. Expression and kinetics of fibrinolytic components in plasma and peritoneum during abdominal surgery. Fibrinolysis 1998; 12: 61-67.
31. Ivarsson M-L, Holmdahl L, Falk P, Mölne J, Risberg B. Characterization and fibrinolytical properties of mesothelial cells isolated from peritoneal lavage. Scand J Clin Lab Invest 1998; 58: 195-204.
32. Johnson FR, Whitting HW. Repair of parietal peritoneum. Br J Surg 1962; 49: 653-660.
33. Jonjic N, Peri G, Bernasconi S, et al. Expression of adhesion molecules and chemotactic cytokines in cultured human mesothelial cells. J Exp Med 1992; 176: 1165-1174.
34. Kaidi AA, Gurchumelidze T, Nazzal M, Figert P, Vanterpool C, Silva Y. Tumor necrosis factor-alpha: a marker for peritoneal adhesion formation. J Surg Res 1995; 58: 516-518.
35. Kaidi AA, Nazzal M, Gurchumelidze T, Ali MA, Dawe EJ, Silva YJ. Preoperative administration of antibodies against tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) and their impact on peritoneal adhesion formation. Am Surg 1995; 61: 569-572.
36. Lanfrancone L, Boraschi D, Ghiara P, et al. Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and IL-6) and are activated and stimulated to grow by IL-1. Blood 1992; 80: 2835-2842.
37. Lucas PA, Warejcka DJ, Young HE, Lee BY. Formation of abdominal adhesions is inhibited by antibodies to transforming growth factor-β1. J Surg Res 1996; 65: 135-138.
38. Luijendijk RW, de Lange DCD, Wauters CCAP, et al. Foreign material in postoperative adhesions. Ann Surg 1996; 223: 242-248.
39. Menzies D, Ellis H. The role of plasminogen activator in adhesion prevention. Surg Gynecol Obstet 1991; 172: 362-366.
40. Montz FJ, Cristoforoni PM, Holschneider C, Punyasavatsut M, Abed E. Anti-interleukin 10: effect on postoperative intraperitoneal adhesion formation in a murine model. In: Treutner KH, Schumpelick V, eds. Peritoneal adhesions. Berlin: Springer, 1997: 72-79.
41. Montz FJ, Fowler JM, Wolff AJ, Lacey SM, Mohler M. The ability of recombinant tissue plasminogen activator to inhibit post-radical pelvic surgery adhesions in the dog model. Am J Obstet Gynecol 1991; 165: 1539-1542.
42. Montz FJ, Holschneider CH, Bozuk M, Gotlieb WH, Martinez-Maza O. Interleukin 10: ability to minimize postoperative intraperitoneal adhesion formation in a murine model. Fertil Steril 1994; 61: 1136-1140.
43. Moore KL, Bang NU, Broadie TA, Mattler LE, Marks CA. Peritoneal fibrinolysis: evidence for the efficiency of the tissue-type plasminogen activator. J Lab Clin Med 1983; 101: 921-929.
44. Ohtani Y, Ohtani O, Nakatani T. Microanatomy of the rat diaphragm: a scanning electron and confocal laser scanning microscopic study. Arch Histol Cytol 1993; 56: 317-328.
45. Orita H, Fukasawa M, Girgis W, diZerega GS. Inhibition of postsurgical adhesions in a standardized rabbit model: intraperitoneal treatment with tissue plasminogen activator. Int J Fertil 1991; 36: 172-177.
46. Raftery AT. Regeneration of parietal and visceral peritoneum: an electron microscopical study. J Anat 1973; 115: 375-392.
47. Räf LE. Causes of small intestinal obstruction. Acta Chir Scand 1969; 135: 67-72.
48. Rong H, Tang XM, Zhao Y, et al. Postsurgical intraperitoneal exposure to glove powder modulates the inflammatory and immune-related cytokine production. Wound Repair Regen 1997; 5: 85-96.
49. Scott-Coombes DM, Badia JM, Whawell SA, Williamson RCN, Thompson JN. Cytokine response to elective surgery: A possible mechanism for intraperitoneal adhesion pathogenesis. In: Treutner K-H, Schumpelick V, eds. Peritoneal adhesions. Berlin: Springer, 1997: 121-126.
50. Shenkin A, Fraser WD, Series J, et al. The serum interleukin 6 response to elective surgery. Lymphokine Res 1989; 8: 123-127.
51. Sheppard BB, de Virgilio C, Bleiweis M, Milliken JC, Robertson JM. Inhibition of intra-abdominal adhesions: fibrin glue in a long term model. Am Surg 1993; 59: 786-790.
52. Sitter T, Gödde M, Spannagl M, Fricke H, Kooistra T. Intraperitoneal coagulation and fibrinolysis during inflammation: In vivo and in vitro observations. Fibrinolysis 1996; 10 (Suppl 2): 99-104.
53. Steinleitner A. Immunomodulation of the acute postinjury phase of mesothelial repair. In: Treutner KH, Schumpelick V, eds. Peritoneal adhesions. Berlin: Springer, 1997: 335-343.
54. Thompson JN, Paterson Brown S, Harbourne T, Whawell SA, Kalodiki E, Dudley HAF. Reduced human peritoneal plasminogen activating activity: possible mechanism of adhesion formation. Br J Surg 1989; 76: 382-384.
55. Tietze L, Elbrecht A, Schauerte C, et al. Modulation of pro- and antifibrinolytic properties of human peritoneal mesothelial cells by transforming growth factor β1 (TGF-β1), tumor necrosis factor α (TNF-α) and interleukin 1β (IL-1β). Thromb Haemost 1998; 79: 362-370.
56. Topley N, Jorres A, Luttman W, et al. Human peritoneal mesothelial cells synthesize interleukin-6: induction by II-1β and TNFα. Kidney Int 1993; 43: 226-233.
57. Topley N, Jorres A, Luttman W, et al. Human peritoneal mesothelial cells synthesize interleukin-8: synergistic induction by interleukin-1β and tumor necrosis factor-α. Am J Pathol 1993; 142: 1876-1886.
58. Tsukada K, Katoh H, Shiojima M, Suzuki T, Takenoshita S, Hagamachi Y. Concentrations of cytokines in peritoneal fluid after surgery. Eur J Surg 1993; 159: 475-479.
59. van der Ham AC, Kort WJ, Weijma IM, van den Ingh HF, Jeekel H. Healing of ischemic colonic anastomosis: fibrin sealant does not improve wound healing. Dis Colon Rectum 1992; 35: 884-891.
60. van der Ham AC, Kort WJ, Weijma IM, van den Ingh HF, Jeekel J. Effect of fibrin sealant on the healing colonic anastomosis in the rat. Br J Surg 1991; 78: 49-53.
61. Vassalli J-D, Pepper MS. Membrane proteases in focus. Nature 1994; 370: 14-15.
62. Walsh J, Wheeler HR, Geczy CL. Modulation of tissue factor on human monocytes by cisplatin and adriamycin. Br J Haematol 1992; 81: 480-488.
63. Wharram BL, Fitting K, Kunkel SL, Remick DG, Merritt SE, Wiggins RC. Tissue factor expression in endothelial cell/monocyte cocultures stimulated by lipopolysaccharide and/or aggregated IgG. Mechanisms of cell:cell communication. J Immunol 1991; 146: 1437-1445.
64. Whawell SA, Scott-Coombes DM, Vipond MN, Terbutt SJ, Thompson JN. Tumor necrosis factor-mediated release of plasminogen activator inhibitor 1 by human mesothelial cells. Br J Surg 1994; 81: 214-216.
65. Whawell SA, Thompson JN. Cytokine-induced release of plasminogen activator inhibitor-1 by human mesothelial cells. Eur J Surg 1995; 161: 315-317.
66. Williams RS, Rossi AM, Chegini N, Schultz G. Effect of transforming growth factor beta on postoperative adhesion formation and intact peritoneum. J Surg Res 1992; 52: 65-70.
67. Zeillemaker AM, Hoynck van Papendrecht AA, Hart MHL, Roos D, Verbrugh HA, Leguit P. Peritoneal interleukin-8 in acute appendicitis. J Surg Res 1996; 62: 273-277.
68. Zeillemaker AM, Mul FP, Hoynck van Papendrecht AA, et al. Polarized secretion of interleukin-8 by human mesothelial cells: a role in neutrophil migration. Immunology 1995; 84: 227-232.